JHS Svendgaard Laboratories Ltd
NSE:JHS
JHS Svendgaard Laboratories Ltd
JHS Svendgaard Laboratories Ltd. engages in the manufacture of oral care and dental products. The company is headquartered in New Delhi, Delhi. The company went IPO on 2006-10-19. The firm is engaged in the manufacturing a range of oral and dental products for elite national and international brands. Its geographical areas include India, United Arab Emirates (UAE) and Singapore. Its fast moving consumer goods (FMCG) sectors include oral care category, personal care, ready-to-eat food and snacks, and fabric care. The Company’s product portfolio includes toothbrushes, toothpastes, mouthwashes, handwashes, beauty care, noodles, washing powder, talcum powders, snacks, creams, shampoos, lotions and soap bars. The Company’s subsidiaries include JHS Svendgaard Mechanical and Warehouse Private Limited and JHS Svendgaard Retail Ventures Private Limited.
JHS Svendgaard Laboratories Ltd. engages in the manufacture of oral care and dental products. The company is headquartered in New Delhi, Delhi. The company went IPO on 2006-10-19. The firm is engaged in the manufacturing a range of oral and dental products for elite national and international brands. Its geographical areas include India, United Arab Emirates (UAE) and Singapore. Its fast moving consumer goods (FMCG) sectors include oral care category, personal care, ready-to-eat food and snacks, and fabric care. The Company’s product portfolio includes toothbrushes, toothpastes, mouthwashes, handwashes, beauty care, noodles, washing powder, talcum powders, snacks, creams, shampoos, lotions and soap bars. The Company’s subsidiaries include JHS Svendgaard Mechanical and Warehouse Private Limited and JHS Svendgaard Retail Ventures Private Limited.
Revenue Outlook: Management guided for 30% to 40% revenue growth in FY '25, backed by confirmed order books and new customer additions.
Margin Expansion: EBITDA margins are expected to reach healthy double digits, specifically mid-teens, in FY '25 due to operational efficiencies, price increases, and improved product mix.
Capacity Utilization: Current plant utilization is 30%–35%; the target is to ramp this up to 70%–80% over the next two years, requiring minimal new CapEx.
Order Book: The company has a firm order book of INR 110 crores for the current year, with expectations to exceed this figure.
Customer Diversification: Reliance and Unilever have been added as new clients, and management is actively reducing overdependence on any single customer.
Export Revival: Exports, which had dropped to 1%–2% of sales during COVID, are showing signs of recovery with improved payment terms.
Product Mix Shift: Toothbrushes now comprise 60% of revenue, with efforts ongoing to grow the toothpaste and other personal care segments.
